Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Abstract 1637: The evolution of patient navigation research models to reduce breast cancer disparities: Case studies of patient navigation dissemination and implementation in Chicago

Melissa A. Simon, Laura S. Tom, Julia R. Trosman, Christine B. Weldon, Catherine A. O'Brian, Marcie C. Kirschner, XinQi Dong

Cancer Res (2018) 78 (13_Supplement): 1637.

DOI: https://doi.org/10.1158/1538-7445.AM2018-1637

Published: 01 July 2018

View article

Journal Articles

A new paradigm for the development of PKCε-targeted small-molecule cancer therapeutics

Feng Chu, Ryuji Kobayashi, Catherine A. O’brian

Cancer Res (2006) 66 (8_Supplement): 518.

Published: 15 April 2006

View article

Journal Articles

Identification of an Inactivating Cysteine Switch in Protein Kinase Cε, a Rational Target for the Design of Protein Kinase Cε–Inhibitory Cancer Therapeutics

Feng Chu, John M. Koomen, Ryuji Kobayashi, Catherine A. O'Brian

Cancer Res (2005) 65 (22): 10478–10485.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-1989

Published: 15 November 2005

View article

Journal Articles

A novel sulfhydryl pharmacophore in the oncogenic protein kinase PKC-epsilon acts as a redox-sensitive switch that inactivates the kinase

Feng Chu, Catherine A. O’Brian

Cancer Res (2005) 65 (9_Supplement): 551.

Published: 01 May 2005

View article

Journal Articles

Disulfiram is a prototype for a new class of cancer preventive agents that counteract the role of PKC in cancer development by differential oxidative regulation of PKC isozymes.

Feng Chu, Li Hua Chen, Catherine A. O’Brian

Cancer Res (2004) 64 (7_Supplement): 517.

Published: 01 April 2004

View article

Journal Articles

Identification of Naturally Processed Human Ovarian Peptides Recognized by Tumor-associated CD8⁺ Cytotoxic T Lymphocytes

Bryan Fisk, Brett W. Anderson, Karen R. Gravitt, Catherine A. O'Brian, Andrzej P. Kudelka, James L. Murray, J. Taylor Wharton, Constantin G. Ioannides

Cancer Res (1997) 57 (1): 87–93.

Published: 01 January 1997

View article

Journal Articles

Site-dependent Differences in Response of the UV-2237 Murine Fibrosarcoma to Systemic Therapy with Adriamycin

Alexander N. Staroselsky, Dominic Fan, Catherine A. O'Brian, Corazon D. Bucana, Krishna P. Gupta, Isaiah J. Fidler

Cancer Res (1990) 50 (24): 7775–7780.

Published: 01 December 1990

View article

Journal Articles

Enhancement of Murine Tumor Cell Sensitivity to Adriamycin by Presentation of the Drug in Phosphatidylcholine-Phosphatidylserine Liposomes

Dominic Fan, Corazon D. Bucana, Catherine A. O'Brian, Leonard A. Zwelling, Christopher Seid, Isaiah J. Fidler

Cancer Res (1990) 50 (12): 3619–3626.

Published: 01 June 1990

View article

Journal Articles

Elevated Protein Kinase C Expression in Human Breast Tumor Biopsies Relative to Normal Breast Tissue

Catherine A. O'Brian, Victor G. Vogel, S. Eva Singletary, Nancy E. Ward

Cancer Res (1989) 49 (12): 3215–3217.

Published: 01 June 1989

View article

Journal Articles

Specific and Direct Binding of Protein Kinase C to an Immobilized Tamoxifen Analogue

Catherine A. O'Brian, Gerard M. Housey, I. Bernard Weinstein

Cancer Res (1988) 48 (13): 3626–3629.

Published: 01 July 1988

View article

Journal Articles

Altered Levels of Protein Kinase C and Ca²⁺-dependent Protein Kinases in Human Colon Carcinomas

José G. Guillem, Catherine A. O'Brian, Cheryl J. Fitzer, Kenneth A. Forde, Paul LoGerfo, Michael Treat, I. Bernard Weinstein

Cancer Res (1987) 47 (8): 2036–2039.

Published: 01 April 1987

View article

Journal Articles

Inhibition of Protein Kinase C by Tamoxifen

Catherine A. O'Brian, Rob M. Liskamp, David H. Solomon, I. Bernard Weinstein

Cancer Res (1985) 45 (6): 2462–2465.

Published: 01 June 1985

View article

NARROW

Abstract 1637: The evolution of patient navigation research models to reduce breast cancer disparities: Case studies of patient navigation dissemination and implementation in Chicago

A new paradigm for the development of PKCε-targeted small-molecule cancer therapeutics

Identification of an Inactivating Cysteine Switch in Protein Kinase Cε, a Rational Target for the Design of Protein Kinase Cε–Inhibitory Cancer Therapeutics

A novel sulfhydryl pharmacophore in the oncogenic protein kinase PKC-epsilon acts as a redox-sensitive switch that inactivates the kinase

Disulfiram is a prototype for a new class of cancer preventive agents that counteract the role of PKC in cancer development by differential oxidative regulation of PKC isozymes.

Identification of Naturally Processed Human Ovarian Peptides Recognized by Tumor-associated CD8⁺ Cytotoxic T Lymphocytes

Site-dependent Differences in Response of the UV-2237 Murine Fibrosarcoma to Systemic Therapy with Adriamycin

Enhancement of Murine Tumor Cell Sensitivity to Adriamycin by Presentation of the Drug in Phosphatidylcholine-Phosphatidylserine Liposomes

Elevated Protein Kinase C Expression in Human Breast Tumor Biopsies Relative to Normal Breast Tissue

Specific and Direct Binding of Protein Kinase C to an Immobilized Tamoxifen Analogue

Altered Levels of Protein Kinase C and Ca²⁺-dependent Protein Kinases in Human Colon Carcinomas

Inhibition of Protein Kinase C by Tamoxifen

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only